Table 2.
TDRa(n, %) | 2000–2005 (n=350)6,12 | 2006–2010 (n=251)7–11 | This study (n=131) | p-value |
---|---|---|---|---|
K103N | 2 (0.6) | 2 (0.8) | 8 (6.1) | <0.001 |
Overallb | 14 (4.0) | 4 (1.5) | 11 (8.5) | 0.006 |
Study period was determined as the median time of sample collection in each study.
Overall transmitted drug resistance (TDR) prevalence of prior studies was reestimated according to the 2009 WHO HIV Surveillance Drug Resistance Mutation list.